Display options
Cite
Xu L, Wang QZ, Wu L. Adenocarcinoma of the lung with . Onco Targets Ther. 2017;10:4517-4525doi: 10.2147/OTT.S143501.
Xu, L., Wang, Q. Z., & Wu, L. (2017). Adenocarcinoma of the lung with . OncoTargets and therapy, 104517-4525. https://doi.org/10.2147/OTT.S143501
Xu, Li, et al. "Adenocarcinoma of the lung with ." OncoTargets and therapy vol. 10 (2017): 4517-4525. doi: https://doi.org/10.2147/OTT.S143501
Xu L, Wang QZ, Wu L. Adenocarcinoma of the lung with . Onco Targets Ther. 2017 Sep 12;10:4517-4525. doi: 10.2147/OTT.S143501. eCollection 2017. PMID: 28979143; PMCID: PMC5602471.
Copy Download .nbib Format: NLM
Share it on

Onco Targets Ther. 2017 Sep 12;10:4517-4525. doi: 10.2147/OTT.S143501. eCollection 2017.

Adenocarcinoma of the lung with .

OncoTargets and therapy

Li Xu, Qian Z Wang, Lin Wu

Affiliations

  1. Department of the Second Chest Medicine, Hunan Cancer Hospital, Changsha, Hunan, People's Republic of China.
  2. Department of the Second Chest Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.

PMID: 28979143 PMCID: PMC5602471 DOI: 10.2147/OTT.S143501

Abstract

The treatment of lung cancer has made paradigm-shift advancements in the past decade with the development of therapies directed at specific genetic alterations, such as epidermal growth factor receptor (

Keywords: PI3K/Akt/mTOR pathway; T790M; circulating tumor DNA; epidermal growth factor receptor; next-generation sequencing

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. N Engl J Med. 2009 Sep 3;361(10):947-57 - PubMed
  2. Clin Cancer Res. 2016 Feb 15;22(4):915-22 - PubMed
  3. Nat Rev Cancer. 2009 Aug;9(8):550-62 - PubMed
  4. Int J Cancer. 2006 Jan 1;118(1):209-14 - PubMed
  5. Clin Cancer Res. 2013 Apr 15;19(8):2240-7 - PubMed
  6. J Cell Mol Med. 2010 Jan;14(1-2):51-69 - PubMed
  7. Clin Cancer Res. 2014 Mar 1;20(5):1383-92 - PubMed
  8. Clin Cancer Res. 2015 Aug 15;21(16):3631-9 - PubMed
  9. BMC Cancer. 2011 Apr 20;11:147 - PubMed
  10. Oncotarget. 2016 Sep 20;7(38):61755-61763 - PubMed
  11. N Engl J Med. 2017 Feb 16;376(7):629-640 - PubMed
  12. Clin Cancer Res. 2008 May 15;14(10):2895-9 - PubMed

Publication Types